THE EFFECT OF SGLT2 INHIBITOR THERAPY ON THE COURSE OF ATRIAL FIBRILLATION IN PATIENTS WITH CHRONIC KIDNEY DISEASE. scientific [Internet]. 2026 Jan. 26 [cited 2026 Feb. 28];86(2):148-50. Available from: https://journalss.org/index.php/obr/article/view/16527